Condition
Catabolic State
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed5
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04467619Not ApplicableCompletedPrimary
Illusory Movements in Patients With Burns
NCT04998643Unknown
Muscle Catabolism and Outcomes in Children Following Cardiac Surgery
NCT04266015Not ApplicableCompleted
Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery
NCT04037722Not ApplicableCompleted
Echocardiographic Changes After 3-hydroxy Butyrate+Whey Intake
NCT04056286Not ApplicableCompleted
Gastro-intestinal and Hormonal Responses to Systemic Inflammatory Disease
NCT04064268Not ApplicableCompleted
Anabolic Potential of 3-hydroxybutyrate (3-OHB) and Whey Protein in a Human Catabolic Inflammatory Disease Model
Showing all 6 trials